Expression Analysis Purchases its First Illumina Genome Analyzer
News Jan 09, 2009
Illumina has announced that Expression Analysis, an Illumina certified service provider (CSPro) has purchased its first Genome Analyzer. With this purchase, Expression Analysis becomes the only CSPro that owns all four of Illumina's genomic research platforms: Genome Analyzer, iScan, BeadStation, and BeadXpress.
"We continue to invest in Illumina's technology because of the significant client demand for their genomic research platforms," said Steve McPhail, President and CEO of Expression Analysis.
"At next week's Plant and Animal Genome Conference we will launch our new agricultural genomics services offering. The Genome Analyzer plays a critical role in this program because of its ability to offer a broad range of sequencing applications to support comprehensive DNA, gene expression and regulation, and epigenomics-based studies, for this market segment."
New Inherited Neurodevelopmental Disease DiscoveredNews
Researchers have identified a new inherited neurodevelopmental disease that causes slow growth, seizures and learning difficulties in humans.READ MORE
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE